Vitamin E versus no treatment for improving fertility
Part of Women’s health & pregnancy clinical trials.
This study tests whether taking vitamin E before IVF helps improve fertility compared with no additional treatment. It may help women with low egg reserve (AMH levels between 0.1 and 1.1 ng/mL) who are planning IVF.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 35 and 42 years old.
- You have been trying to get pregnant and are planning to do IVF (in vitro fertilization) with a specific medication plan called an antagonist protocol.
- Your AMH (a hormone that indicates egg supply) is between 0.1 and 1.1 ng/mL.
- You have both ovaries.
- You are willing to sign a consent form and follow the study's rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This trial tests whether giving a hormone called hCG before starting IVF can improve outcomes for women with low egg reserve (low AMH). It is designed for women under 40 who are early in their IVF journey.
This study measures changes in your blood immune markers during frozen embryo transfer when the embryo is chromosomally normal. It may help clinics understand what blood immune patterns relate to successful pregnancy in natural or hormone-prepared cycles.
This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.
This trial tests whether taking testosterone before IVF can improve egg quality and pregnancy chances in women with low ovarian reserve. It is specifically for women with a certain genetic marker in the androgen receptor.
This study tests whether etanercept, a drug that reduces inflammation, can improve the chances of having a baby in women with low ovarian reserve who are undergoing IVF. It may help by calming the immune system to create a better environment for embryo implantation.
Hear when a new Infertility, Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.